Jan 30, 2017 11:30 am UTC| Business
VANCOUVER, Washington, Jan. 30, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces the...
Capstone Companies Announces Over 85% Growth in 2016
Jan 30, 2017 11:30 am UTC| Business
DEERFIELD BEACH, Fla., Jan. 30, 2017 -- Capstone Companies, Inc. (OTCQB:CAPC) (“Capstone” or the “Company”), a designer of innovative LED lighting solutions including power failure lighting, today announced preliminary...
JBS S.A. Announces Independent Members of the Board of Its Subsidiary JBS Foods International
Jan 30, 2017 11:06 am UTC| Business
SAO PAULO, Brazil , Jan. 30, 2017 -- JBS S.A. (BMFBOVESPA:JBSS3) (OTCQX:JBSAY) ("JBS" or "Company"), announces to its shareholders and the market in general the appointment of independent members of the Board of its...
Summit Financial Group Reports Fourth Quarter and Full Year 2016 Results
Jan 30, 2017 11:00 am UTC| Business
Q4 2016 Diluted EPS $0.44 compared to $0.39 for Q4 2015 and $0.40 for Q3 2016; Full year 2016 Diluted EPS $1.61 compared to $1.50 for 2015 MOOREFIELD, W. Va., Jan. 30, 2017 -- Summit Financial Group, Inc. (“Company”...
Gemphire Announces Interim LDL-C Lowering Data from COBALT-1 Phase 2b Clinical Trial
Jan 30, 2017 11:00 am UTC| Business
LIVONIA, Mich., Jan. 30, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) today announced interim data on the LDL-C primary endpoint from the ongoing open label COBALT-1 trial. COBALT-1 is investigating gemcabene in...
Jan 30, 2017 11:00 am UTC| Business
SALT LAKE CITY, Jan. 30, 2017 -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) reprints by permission of the University of South Florida (USF) Technology Transfer Office this press release published on January 19,...
CapStar Financial Holdings, Inc. Announces Fourth Quarter 2016 Results
Jan 30, 2017 11:00 am UTC| Business
NASHVILLE, Tenn., Jan. 30, 2017 -- CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) reported net income of $2.9 million, or $0.23 per share on a fully diluted basis, for the three months ended December 31,...